The head of German pharmaceutical company BioNTech said on Monday that there is no need to waive patents on coronavirus vaccines because manufacturers will be able to produce enough shots to supply the world over the coming year.

Vaccine maker BioNTech says no need to waive patents 

Losses caused by payments to be made to customers for cheating on fuel economy tests -- since 1991

Mitsubishi Motors to post USD 480m loss for the year

maker

Maker, News on Maker, stories on Maker, articles on Maker, Maker stories at Wion, Maker news, Maker latest news